Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease

<p>Abstract</p> <p>Clinical trials aiming to assess the safety and efficacy of fetal cell transplantation in Parkinson's disease rely on the hypothesis that the grafted tissue will survive and grow, restore striatal dopaminergic neurotransmission, improve the connectivity betw...

Full description

Bibliographic Details
Main Author: Politis Marios
Format: Article
Language:English
Published: BMC 2011-05-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/9/50
id doaj-ffd98ca2593b4122a9dc3ef2a6112c18
record_format Article
spelling doaj-ffd98ca2593b4122a9dc3ef2a6112c182020-11-24T21:22:35ZengBMCBMC Medicine1741-70152011-05-01915010.1186/1741-7015-9-50Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's diseasePolitis Marios<p>Abstract</p> <p>Clinical trials aiming to assess the safety and efficacy of fetal cell transplantation in Parkinson's disease rely on the hypothesis that the grafted tissue will survive and grow, restore striatal dopaminergic neurotransmission, improve the connectivity between striatum, thalamus and cortex and, thereby, produce long-lasting clinical improvement while avoiding the development of adverse effects. Although transplantation of human fetal ventral mesencephalic tissue has been reported as one of the most effective reparative therapies in Parkinson's disease patients to date, different studies have shown inconsistent results causing a paucity of new trials over the last decade. However, during this period, functional imaging alongside other scientific developments from clinical observations and animal work has significantly aided in understanding the mechanisms responsible for the success or failure of grafting human fetal tissue. Recent advances in functional imaging including both positron emission tomography and functional magnetic resonance imaging could be proven useful <it>in vivo </it>tools for the development and assessment of new clinically competitive trials. In this commentary we discuss how an optimized functional imaging protocol could assist new clinical trials using fetal cell transplantation in Parkinson's disease.</p> http://www.biomedcentral.com/1741-7015/9/50
collection DOAJ
language English
format Article
sources DOAJ
author Politis Marios
spellingShingle Politis Marios
Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
BMC Medicine
author_facet Politis Marios
author_sort Politis Marios
title Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
title_short Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
title_full Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
title_fullStr Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
title_full_unstemmed Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
title_sort optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in parkinson's disease
publisher BMC
series BMC Medicine
issn 1741-7015
publishDate 2011-05-01
description <p>Abstract</p> <p>Clinical trials aiming to assess the safety and efficacy of fetal cell transplantation in Parkinson's disease rely on the hypothesis that the grafted tissue will survive and grow, restore striatal dopaminergic neurotransmission, improve the connectivity between striatum, thalamus and cortex and, thereby, produce long-lasting clinical improvement while avoiding the development of adverse effects. Although transplantation of human fetal ventral mesencephalic tissue has been reported as one of the most effective reparative therapies in Parkinson's disease patients to date, different studies have shown inconsistent results causing a paucity of new trials over the last decade. However, during this period, functional imaging alongside other scientific developments from clinical observations and animal work has significantly aided in understanding the mechanisms responsible for the success or failure of grafting human fetal tissue. Recent advances in functional imaging including both positron emission tomography and functional magnetic resonance imaging could be proven useful <it>in vivo </it>tools for the development and assessment of new clinically competitive trials. In this commentary we discuss how an optimized functional imaging protocol could assist new clinical trials using fetal cell transplantation in Parkinson's disease.</p>
url http://www.biomedcentral.com/1741-7015/9/50
work_keys_str_mv AT politismarios optimizingfunctionalimagingprotocolsforassessingtheoutcomeoffetalcelltransplantationinparkinsonsdisease
_version_ 1725995263607177216